The blood glucose test strips are plastics or
thin papers which are majorly used to determine the blood glucose levels for
controlling the diabetes. The sectors in the blood glucose test strips industry
are dependent on the type of the reactive enzyme used in the glucose
dehydrogenase and strips-glucose oxidase, by the category of the electrode
used-thick film, optical and thin film. Whereas, thick film electrodes are used
on a large scale followed by thin film and optical based test strips. Moreover,
glucose dehydrogenase-based test strips are the utmost accurate and of the
strips and registered for two-thirds of all supply. In the market, the major
trend of shaping the blood glucose test strips involve the effective
development of generic blood glucose test strips, new FDA strategies on the
definite of blood glucose recognition, innovative blood glucose test ways and
reasonable alternative silk strips. Moreover, the development in the healthcare
industry and increase in the awareness are the major growth drivers of this
market across the globe in the recent trend.
According to the report analysis, ‘Blood
Glucose Test Strips Global Market Opportunities And Strategies To 2021
Including: Thick Film Electrochemical Films, Thin Film Electrochemical Films
and Optical Strips Covering: LifeScan, Roche Holding AG, Abbott Laboratories,
Ascensia, Trividia Health(Nipro Diagnostics)’ some of the major
companies which are currently functioning in this domain with the effective
technology for accomplishing the demand of the potential buyers and attaining
the effective shares includes Medtronic plc, LifeScan, Inc., Abbott Diabetes
Care, Eli Lilly and Co., Johnson & Johnson, Ascensia Diabetes Care Holdings
AG, Tandem Diabetes Care, Acon Laboratories Inc., Arkray Inc., Terumo Corporation,
Osang Healthcare Co., Ltd., Bhat Bio - Tech India Pvt. Ltd., NIPRO Medical
Corporation, Bionime Corp., Wuhan Fine Biotech, F. Hoffmann-La Roche, Roche
Diabetes Care, GlaxoSmithKline plc, Bayer HealthCare AG, Novo Nordisk, B. Braun
Melsungen, Medisana AG, Sanofi, Norditalia, Emperra, Vedalab, Wellion, 77
Elektronika Kft., Norma, Iquego, Roche Diagnostic, Life Scan Inc., Bayer
HealthCare, Dario Health, Kuteks, Bayer Healthcare AG, LifeScan, F. Hoffmann-La
Roche, Arkay Inc. and several others.
Major drivers of this market in the historic
period include increased disposable income, increased diabetes cases and
effective technological advances, meanwhile the major restraints on the market
involved lack in awareness, development of alternative technologies for blood
glucose monitoring and decreased reimbursement prices. Moreover,
geographically, with the extensive usage of blood glucose test strips, the
market is spread across the globe which includes North America, Asia Pacific
region, Western Europe, Easter Europe, South America, Middle East, Africa and
rest of the world. Whereas, the market of glucose test strips across the globe
was worth USD 10.6 billion in 2017 while the size of the market influenced by
the prevalence of diabetes and increased awareness of self-monitoring of blood
glucose. In 2017, the North America region was the highest market for this and
worth 47.1% of the market at the effective USD of 5.0 billion. However,
decreasing prices for blood glucose test strips around the world and significant
increase in the competition from local players the market will grow more
actively across the globe over the decades.
For more information, click on the
link below:
Contact Us:
Ken
Research
Ankur
Gupta, Head Marketing & Communications
+91
9015378249